C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
12/2002
12/31/2002	US6500839 CRF receptor antagonists and methods relating thereto
12/27/2002	WO2002102808A2 (PYRIDO/THIENO)-[f]-OXAZEPIN-5-ONE DERIVATIVES AS POSITIVE MODULATORS OF THE AMPA RECEPTOR
12/27/2002	WO2002102807A1 Novel isoxazolopyridone derivatives and use thereof
12/27/2002	WO2002102793A2 Quinazolinediones as antibacterial agents
12/27/2002	WO2002102792A1 Novel heterocyclic antibacterial compounds
12/27/2002	WO2002102315A2 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
12/27/2002	WO2002102314A2 Purine inhibitors of phosphodiesterase (pde) 7
12/27/2002	WO2002102313A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002	WO2002062335A3 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
12/27/2002	CA2451057A1 Novel isoxazolopyridone derivatives and use thereof
12/27/2002	CA2450936A1 Purine inhibitors of phosphodiesterase (pde) 7
12/27/2002	CA2450934A1 Pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002	CA2450724A1 Quinazoline and pyrido¬2,3-d\|pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002	CA2446963A1 Quinazolinediones as antibacterial agents
12/26/2002	US20020198217 Such as benzyl-(-7,8-dihydro-2,6,9-trioxa-3-aza-cyclopenta(a)naphthalen-8-ylmethyl) -amine; for treatment of drug dependence/addiction, bipolar disorder, Parkinson's disease, levodopa induced psychoses or dyskinesias
12/26/2002	US20020198198 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
12/26/2002	US20020198190 Tetracyclic 1,2,3,4,5,6- hexahydroazepino-(4,5-b)indole derivatives having a ring connecting position 6 (N-6) and position 7 (C-7); treating or preventing a disease or disorder of the central nervous system in a mammal
12/26/2002	US20020198178 Viricides for preventing infection by HIV, treating infection by HIV, delaying of the onset of AIDS, or treating AIDS
12/25/2002	CN1097056C Counterpart of camptothecin, their application as medicine and pharmaceutical compositions contg. them
12/25/2002	CN1097054C Tricyclic pyrazole derivs. and composition
12/25/2002	CN1097053C 1,2,3,4-tetrahydro-benzofuro [3,2-c] pyridine derivs., preparing method and use thereof
12/24/2002	US6498255 Cholinesterase inhibitors; cognition activators; alzheimer's disease; e.g., 3-(2-(1-(phenylmethyl)-4-piperidinyl)ethyl)-1,2-benzisoxazole
12/24/2002	US6498251 Tetrahydrobenzindole derivatives
12/24/2002	US6498167 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/24/2002	US6498159 Such as 4-((3-chloro-4-methoxybenzyl)amino)-1-((4-hydroxy-4 -hydroxymethyl)piperidino)-6-phthalazine carbonitrile
12/24/2002	CA2150812C Catechol diethers as selective pde iv inhibitors
12/19/2002	WO2002100886A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
12/19/2002	WO2002100865A1 Benzoxazepine derivatives and their use as ampa receptor stimulators
12/19/2002	WO2002100860A2 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
12/19/2002	WO2002100399A1 Macrocycles useful in the treatment of alzheimer's disease
12/19/2002	WO2001047919A9 Substituted oxazolidinones and their use in the field of blood coagulation
12/19/2002	US20020193365 Azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene as 5-HT1A antagonists
12/19/2002	US20020193364 For therapy of central nervous system (CNS) diseases
12/19/2002	US20020193360 For enhancing cognition or in the treatment of diseases of cognitive dysfunction including but not limited to Alzheimer's Disease (AD), mild cognitive impairment, age-related cognitive decline, vascular dementia, Parkinson's disease
12/19/2002	CA2450167A1 Macrocycles useful in the treatment of alzheimer's disease
12/18/2002	EP1266950A1 Lubricant composition containing a triazine molecular complex compound
12/18/2002	EP1266900A1 Carbamates of rapamycin
12/18/2002	EP1266899A2 Rapamycin hdroxyesters, process for their preparation and pharmaceutical compositions containing them
12/18/2002	EP1265909A2 Process for the preparation of 6-o-propargyl erythromycin derivatives
12/18/2002	EP0869949B1 Benzoxazine antimicrobial agents
12/18/2002	EP0650357B1 Rapamycin derivatives
12/18/2002	CN1386120A 萘酚衍生物 Naphthol derivative
12/18/2002	CN1096464C 2,3-benzodiazepine derivatives, its preparation and intermediate and use as medicine
12/18/2002	CN1096463C Procss for producing ecteinascidin and intermediate of said process
12/17/2002	US6495699 Antiarthritic agents; osteoporosis
12/17/2002	US6495544 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase
12/17/2002	US6495543 Treating or preventing melatoninergic disorders
12/17/2002	US6495542 Such as 2-methoxy-n-(2-methyl-1h-benzimidazol-4-yl)-4-(2,3,4,5-tetrahydro-5-oxo-1h-1-benzazepin-1-yl)carbonyl-benzam ide; hypertension, heart failure, renal insufficiency, edema, ascites, vasopressin parasecretion syndrome
12/12/2002	WO2002098883A1 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
12/12/2002	WO2002098850A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002	US20020188015 Method and composition for rejuvinating cells, tissues organs, hair and nails
12/12/2002	US20020187998 Local ophthalmic agent for treatment of ocular inflammation
12/12/2002	CA2448418A1 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/11/2002	EP0981521B1 Novel macrocyclic compounds as metalloprotease inhibitors
12/11/2002	EP0863891B1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/10/2002	US6492520 Substituted pyrido-or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
12/10/2002	US6492513 Method for separating a lactone-containing high-molecular weight compound having an alkyl group as its side chain from a lactone-containing high-molecular weight compound having an alkenyl group as its side chain, said lactone-containing
12/10/2002	US6492396 Substituted thioacetamides
12/10/2002	US6492355 Adamantane derivatives
12/10/2002	CA2086925C New salts derived from dialkylaminoalkysulphonyl-26 pristinamycin iib
12/05/2002	WO2002096516A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002	WO2002096419A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases
12/05/2002	WO2002059116A3 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
12/05/2002	US20020183354 For therapy of depression and other diseases such as obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders
12/05/2002	US20020183353 For therapy of depression, obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse
12/05/2002	US20020183348 Novel polyketide derivatives
12/05/2002	US20020183334 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder
12/05/2002	US20020183314 For therapy of acne, male- pattern baldness, sexual dysfunction, impotence, wasting diseases, hirsutism, hypogonadism, prostatic hyperplasia, osteoporosis, cancer cachexia, and hormone-dependent cancers
12/05/2002	CA2448248A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases
12/05/2002	CA2447657A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/04/2002	EP1262477A1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
12/04/2002	EP1262475A1 Indole derivatives, process for preparation of the same and use thereof
12/04/2002	EP1261606A1 Substituted oxazolidinones and their use in the field of blood coagulation
12/04/2002	EP1261336A2 Il-8 receptor antagonists
12/04/2002	EP1051420B1 New cytotoxic tris(oxazole)-containing macrolides
12/04/2002	EP0901494B1 Photochromic spiroxazines with an asymmetric monocyclic substituent, compositions and articles containing them
12/04/2002	EP0650356B1 Rapamycin derivatives
12/03/2002	US6489351 Condensed 4,5,6,7-tetrahydrobenzo[C]thiophenes as enhancer for cell differentation induction factor action
12/03/2002	US6489340 Macrolide compounds for inducing chondrogenic differentiation
12/03/2002	US6489323 Inhibiting no production from l-arginine, as seen in disease states such as arthritis and systemic hypotension associated with septic and/or toxic shock
12/03/2002	US6489320 5, 5-disubstituted-1, 5-dihydro-4, 1-benzoxazepin-2 (3H)-ones useful as HIV reverse transcriptase inhibitors
12/03/2002	US6489315 Cyclic compounds, their production and use
12/03/2002	CA2263500C Malonate derivatives useful as intermediates for producing isoxazolidinadione hypoglycemic agents
12/03/2002	CA2074933C Thiazole derivatives as active superoxide radical inhibitors
11/2002
11/28/2002	WO2002094844A2 Antiviral nucleosides
11/28/2002	WO2002094833A1 Novel pyrrole derivatives as pharmaceutical agents
11/28/2002	WO2002094797A1 Oxazin(thi)one compounds used as fungicides
11/28/2002	WO2002094796A2 Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases
11/28/2002	WO2002094325A2 Cytotoxic cd44 antibody immunoconjugates
11/28/2002	WO2002094225A1 Granular preparations of gaboxadol
11/28/2002	WO2002044153A8 4-6-diphenyl pyridine derivatives as antiinflammatory agents
11/28/2002	CA2826505A1 Antiviral nucleosides
11/28/2002	CA2447603A1 Granular preparations of gaboxadol
11/28/2002	CA2446620A1 Antiviral nucleosides
11/28/2002	CA2446141A1 Oxazin(thi)one compounds used as fungicides
11/28/2002	CA2443438A1 Cytotoxic cd44 antibody immunoconjugates
11/27/2002	EP1259510A2 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
11/27/2002	EP1259489A1 Aryl fused azapolycyclic compounds
11/27/2002	CN1382126A Bleach boosting components, compositions and laundry methods
11/27/2002	CN1094941C Pyridobenzoxazine derivatives

1 ... 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 ... 220